Announcements Trials
Browse Landscape

Phase

Phase 2 95Phase 3 37Phase 1 22Phase 1/2 11Phase NA 6Phase 2/3 6Phase 4 3Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 3Colonic Neoplasms 3Keratosis, Actinic 2Head and Neck Neoplasms 2Uterine Cervical Dysplasia 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Neuritis 1Mucositis 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1Borderline Resectable Pancreatic Adenocarcinoma 1

Interventions

Fluorodeoxyglucose F18 3Oncolytic Virotherapy 2Magnetic Resonance Spectroscopy 2Cisplatin 2weifuchun 1sodium thiosulfate 1s-formylglutathione hydrolase 1lenvatinib 1gallium 68 PSMA-11 1X-Rays 1Vitamins 1Trastuzumab 1Specimen Handling 1Radiation 1Platinum 1Oxaliplatin 1Nelfinavir 1Hyperthermic Intraperitoneal Chemotherapy 1Fluorouracil 1FAPI-46 1Esomeprazole 1Epirubicin 1Drug Therapy, Combination 1Doxorubicin 1Cytoreduction Surgical Procedures 1Carbohydrates 1Amoxicillin 168Ga-DKFZ-PSMA-11 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Stomach Neoplasms × Fluorouracil × Clear all
NCT00215514 2014-07-29

Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma

Dana-Farber Cancer Institute

Phase EARLY_PHASE1 Completed
25 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡